In order to study the relationship between amiodarone‐induced hepatic phospholipidosis
and liver disease, liver biopsies obtained from 13 patients treated with amiodarone for 4 …

• One hundred two patients with recurrent, drug-refractory tachyarrhythmias were treated
with amiodarone for nine±eight months (mean±SD)(range, one to 50 months). Forty-five …

With the increasing use of amiodarone, several unwanted effects have been recognized. We
reviewed 140 patients treated with amiodarone over a 5-year period in an attempt to identify …

Although amiodarone is a highly effective antiarrhythmic agent, it has a high incidence of
side effects, some of which can be serious or even lethal. With close monitoring, side effects …

Amiodarone causes many side effects involving all organ systems (Table VI). Although most
of the side effects are mild and do not limit the use of the drug, there are several that are …

The relationships between size of loading dose and drug concentration, size of maintenance
dose and drug concentration, and pulmonary and cutaneous adverse side effects and drug …

The computed tomographic (CT) chest scans of 11 patients who developed respiratory or
constitutional symptoms while receiving amiodarone therapy were reviewed. CT findings …

Objectives. We sought to assess the odds of experiencing adverse effects with low dose
amiodarone therapy compared with placebo. Background. An estimate of the likelihood of …

The new anti-arrhythmic agent, amiodarone, is increasingly recognized as a cause of
pulmonary toxicity (APT). In the present series, 11 of 171 patients (6.4%) receiving the drug …

The incidence and clinical predictors of amiodarone pulmonary toxicity were examined in
573 patients treated with amiodarone for recurrent ventricular (456 patients) or …